Nevro Company

Nevro provides pain relief solutions for patients suffering from low back pain and other types of chronic pain.

Estimated Revenue: $100M to $500M
Funding Status: IPO
Headquarters: Menlo Park, California, United States
Total Funding: 355750000
Last Funding Date: 2016
Investors Number: 12
Number Of Exists: N/A
Founded Date: 2006
Technology: Neuromodulation
Industry: Biotechnology, Health Care, Health Diagnostics, Pharmaceutical
Last Funding Type: Post-IPO Debt
Investor Type: N/A
Investment Stage: N/A
Employee Number: 501-1000